LifeStance Health Group (LFST) stock forecast for 2022. Forecast tables and graphs.

LifeStance Health Group (LFST) stock forecast for 2022

Last update: September 27, 2023 (11:53)

Sector: Healthcare

The share price of LifeStance Health Group, Inc. (LFST) now

What analysts predict: $9.58
52-week High/Low: $9.59 / $4.22

50/200 Day Moving Average: $8.63 / $6.99

This figure corresponds to the Average Price over the previous 50/200 days. For LifeStance Health Group stocks, the 50-day moving average is the resistance level today.

For LifeStance Health Group stocks, the 200-day moving average is the resistance level today.

Are you interested in LifeStance Health Group stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the LifeStance Health Group stock price in 2022. How much will one LifeStance Health Group share be worth in 2022? Is it worth taking profit / loss on LifeStance Health Group stock now or waiting? What are analysts' forecasts for LifeStance Health Group stock?

We forecast LifeStance Health Group stock performance using neural networks based on historical data on LifeStance Health Group stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. The LifeStance Health Group stock prediction results are shown below and presented as a graph, table and text information.

LifeStance Health Group stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for LifeStance Health Group analysts is $9.58.

Today 200 Day Moving Average is the support level (6.99 $).

50 Day Moving Average is the resistance level (8.63 $).

Historical and forecast chart of LifeStance Health Group stock

The chart below shows the historical price of LifeStance Health Group stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the LifeStance Health Group stock price can be found in the table below.

LifeStance Health Group (LFST) Forecast for 2022

Month Target Pes. Opt. Vol., %

LifeStance Health Group information and performance

LifeStance Health Group, Inc. provides outpatient mental health services to children, adolescents, adults and the elderly through its subsidiaries. It offers patients a range of mental health services, including psychiatric assessment and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder.

The company offers services to patients virtually through its online delivery platform or in person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.

LifeStance Health Group Address


Market Capitalization: 2 986 239 000 $

Market capitalization of the LifeStance Health Group, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of LFST shares in the company outstanding by the market price of one share.

EBITDA: -90 556 000 $

EBITDA of LifeStance Health Group is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth


Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.


Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.44

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.239
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 151.52

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.537

Enterprise Value (EV) /Revenue

EV To EBITDA: -9.74

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 378005000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

LifeStance Health Group price target for 2022 by month

Related stocks from Healthcare sector


All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.